Lung transplant patients in the UK fare better than publicly insured Americans

Publicly insured Americans who undergo lung transplantation for cystic fibrosis fare markedly worse in the long run than both publicly insured patients in the United Kingdom and privately insured Americans, according to the results of a study conducted by researchers from Johns Hopkins in Baltimore and UK colleagues working in that nation’s government-funded National Health Service. —> Read More